Top Banner
Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users. Short title Identification Of Novel psychoActive substances (IONA)
20

Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Feb 25, 2021

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards OVERVIEW

Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by

laboratory analysis of biological samples from recreational drug users.

Short title

Identification Of Novel psychoActive substances (IONA)

Page 2: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards IONA Study

OverviewNational Poisons

Information Service• Edinburgh

• Newcastle

• Birmingham

• Cardiff

NHS Toxicology labs• Wansbeck

• Birmingham

• Cardiff

Forensic Toxicology labs• Scottish Police Authority

(Edinburgh)

NHS Hospitals• Bart’s, London

• Blackpool

• Cardiff

• Edinburgh

• Liverpool

• London Hospital

• Newcastle

• Northumbria

• North Manchester

• Plymouth

• Southport & Omskirk

• St Georges, London

• St Thomas’, London

• ..more to follow

HPRU Newcastle• Laboratory analysis

• Data processing

Clinical data

from cases of

suspected NPS

exposure

Data on samples

positive for NPS

Samples for

identification of

NPS

Samples and

clinical data

from patients

with severe

NPS toxicity

Page 3: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards IONA Study

Overview

Identify trends in enquiries to the NPIS (telephone and internet) relating to NPS and characterize and monitor the epidemiology of reported exposures

Identify trends in the numbers of samples positive for NPS as identified in participating NHS laboratories

Develop sophisticated mathematical models for analyzing NPIS and toxicology laboratory data

Further develop methods of screening, analysis and quantification for new/emerging NPS in biological samples (urine, oral fluid and blood)

Analyse samples from patients with acute severe toxicity relating to NPS to identify responsible agents

Link the presence of analytically confirmed NPS exposure with the toxic effects experienced

Page 4: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards

Study 4. Collection of samples for research purposes from people

attending participating emergency departments (Post amendment 1)

Study 4

Inclusion criteria Exclusion criteria

Patient with suspected novel

psychoactive substance exposure

Presence of severe acute toxicity

(See text)

Patient consent (immediate or

retrospective)

Refusal of consent

Absence of severe toxicity

Children and young people <16 y

Samples collected for investigation of

suspected non-accidental injury

IONA StudyOverview

Page 5: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards

IONA StudyRecruitment

Page 6: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards

Criteria for severe toxicity (present at any time after exposure)

(Post amendment 1)

Fever > 38.5 oC

Clinically important hypothermia

Glasgow coma scale < 8a

ITU/HDU/CCU admission

Respiratory insufficiency

Requirement for intubation and ventilation

Seizures

Hallucinations/psychosis

Extreme agitation

Severe or prolonged (> 24 h) behavioural disturbance

Arrhythmia

Chest pain or ECG evidence of cardiac ischaemia or myocardial infarction

Acidosis (arterial or venous pH < 7.35 or bicarbonate < 20 mmol/L)

Severe electrolyte or fluid disturbances

Hypoglycaemia (<1.7 mmol/L)

Methaemoglobinaemia (>50%)

Tachycardia > 140 /min

SBP > 180 mmHg

SBP < 80 mmHg

Acute kidney injuryb

Creatine kinase activity raised (> 1000 IU/L)

ALT/AST activity > 300 IU/L

PT > 15 s or INR > 1.3

Death

Poisons Severity Score61 of 3 (Severe) c

Other severe manifestations of toxicity, as determined and justified by the investigator

aIn the absence of likely alternative causes (e.g. severe alcohol intoxication, use of sedative drugs etc).bDefined as a rise in serum creatinine of ≥26 micromol/litre within 48 hours, a 50% or greater rise in serum creatinine

known or presumed to have occurred within the past 7 days, or a fall in urine output to less than 0.5 ml/kg/hour for more

than 6 h63

cCriteria for PSS 3 relevant to recreational drug use include abnormal chest Xray with symptoms, generalized paralysis,

blindness or deafness

Page 7: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards Study website

http://www.ncl.ac.uk/hpru/research/neuro/nps/

Page 8: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards Participant information sheet

Page 9: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards Consent form

Page 10: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards Consultee information sheet

Page 11: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards Consultee declaration form

Page 12: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards

Consent form (person previously included when they did not have capacity

Page 13: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards

Consent form (person previously included when they did not have capacity

Page 14: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards Data provided

• Clinical records retained by the local researcher.

• Information passed on to the research team in Newcastle will include – study number

– the age, sex and postcode (first 4 digits) of the patient

– nature and timing of the exposure

– timing of sample collection

– recorded clinical features (structured data collection form).

– The great majority of samples and data will be provided with consent

– there will be a small number of samples collected without consent from adults with incapacity by means of appropriate declarations from consultees (England and Wales)

Page 15: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards

Page 16: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards Case report form

(Page 1)

Page 17: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards Data collection sheet (Jan 2016 Version)

(page 1)

Page 18: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards Data collection sheet (Jan 2016 Version)

(page 2)

Page 19: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards

Page 20: Chemical and Radiation Threats and Hazards OVERVIEW...Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive

Chemical and Radiation Threats and Hazards Contact details

• Simon Thomas (CI)

• Tel 0191 2824642

• email [email protected]